MedTrace Logo

The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19

NCT04647734 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-06-08

No results posted yet for this study

Summary

40 COVID-19 survivors that have been discharged from the hospital will be included in this investigator-blinded randomised study with a 12-week exercise intervention. Patients will be 1:1 block-randomised by sex to either a supervised high intensity interval-based exercise group or standard care (control group).

Conditions

  • COVID-19, SARS-CoV2

Interventions

BEHAVIORAL

High intensity interval training

12 weeks of high intensity interval training on exercise bike for 38 minutes 3 times a week

BEHAVIORAL

Standard care

standard care after discharge from hospital (control group)

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Regitse Christensen, MD, PhD · Center for Physical Activity Research, Rigshospitalet

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-02-01
Completion
2022-02-10

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04647734 on ClinicalTrials.gov